{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:27:49Z","timestamp":1789694869409,"version":"4.0.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jceh.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T21:49:38Z","timestamp":1593640178000},"page":"239-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term Management of the Adult Liver Transplantation Recipients"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-0036","authenticated-orcid":false,"given":"Narendra S.","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-7140","authenticated-orcid":false,"given":"Sanjiv","family":"Saigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvinder S.","family":"Soin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2020.06.010_bib1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for Mortality post-liver transplant: results of the NIDDK long term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0b013e31821841ba","article-title":"The pattern of late mortality in liver transplant recipients in the United Kingdom","volume":"91","author":"Gelson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/TP.0000000000001710","article-title":"Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review","volume":"101","author":"Konerman","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/lt.23508","article-title":"Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies","volume":"18","author":"Madhwal","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/lt.25055","article-title":"Hospitalizations for cardiovascular disease after liver transplantation in the United States","volume":"24","author":"Khurmi","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/lt.24137","article-title":"Cardiovascular disease after liver transplantation: when, what, and who is at risk","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/TP.0000000000002175","article-title":"Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation","volume":"102","author":"VanWagner","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4254\/wjh.v10.i10.761","article-title":"Liver transplantation and atrial fibrillation: a meta-analysis","volume":"10","author":"Chokesuwattanaskul","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib9","doi-asserted-by":"crossref","first-page":"53E","DOI":"10.1016\/j.amjcard.2005.06.006","article-title":"Recent national cholesterol education program adult treatment panel III update: adjustments and options","volume":"96","author":"Stone","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jceh.2020.06.010_bib10","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2020.06.010_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ctr.12505","article-title":"Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation","volume":"29","author":"Choudhary","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/liv.12495","article-title":"Prospective evaluation of metabolic syndrome and its components among long-term liver recipients","volume":"34","author":"Anast\u00e1cio","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.06.010_bib15","first-page":"183","article-title":"Metabolic and cardiovascular complications in the liver transplant recipient","volume":"28","author":"Luca","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/jhep.2002.30318","article-title":"Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.06.010_bib17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/lt.21588","article-title":"Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression","volume":"14","author":"Bianchi","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib18","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/TP.0000000000002811","article-title":"Body weight parameters are related to morbidity and mortality after liver transplantation: a systematic review and meta-analysis","volume":"103","author":"Beckmann","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib19","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2215\/CJN.09481209","article-title":"Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus","volume":"5","author":"Chakkera","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2020.06.010_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","article-title":"Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematics screening by oral glucose tolerance test","volume":"91","author":"Caillard","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrneph.2010.66","article-title":"Risk factors for new onset diabetes after transplantation","volume":"6","author":"Sharif","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jceh.2020.06.010_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1432-2277.2012.01488.x","article-title":"Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease and allograft failure late after transplant","volume":"25","author":"Israni","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2020.06.010_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/gfm762","article-title":"The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation","volume":"23","author":"Porrini","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ymgme.2011.12.020","article-title":"Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with tacrolimus","volume":"105","author":"Tavira","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.jceh.2020.06.010_bib27","first-page":"881","article-title":"New-onset diabetes after liver transplantation and its impact on complications and patient survival","volume":"7","author":"Lv","year":"2015","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.jceh.2020.06.010_bib28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.tp.0000250361.60415.96","article-title":"Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up","volume":"82","author":"Moon","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/apt.12881","article-title":"The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US","volume":"40","author":"Younossi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.06.010_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ajt.14401","article-title":"Sustained posttransplantation diabetes is associated with long-term major cardiovascular events following liver transplantation","volume":"18","author":"Roccaro","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/jlts.2001.24637","article-title":"Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight","volume":"7","author":"Neal","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5500\/wjt.v6.i1.125","article-title":"Post-transplant dyslipidemia: mechanisms, diagnosis and management","volume":"6","author":"Agarwal","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients","volume":"43","author":"Morrisett","year":"2002","journal-title":"J\u00a0Lipid Res"},{"issue":"Pt 2","key":"10.1016\/j.jceh.2020.06.010_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1042\/bj2750501","article-title":"Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis","volume":"275","author":"Princen","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.jceh.2020.06.010_bib35","first-page":"177","article-title":"Hyperlipidemia in renal transplant recipients","volume":"3","author":"Hricik","year":"2000","journal-title":"Graft"},{"key":"10.1016\/j.jceh.2020.06.010_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jash.2018.01.002","article-title":"Risk factors for arterial hypertension after liver transplantation","volume":"12","author":"Di Stefano","year":"2018","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.jceh.2020.06.010_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.transproceed.2014.10.050","article-title":"Prevalence of hypertension after living-donor liver transplantation: a prospective study","volume":"47","author":"Tong","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jceh.2013.04.005","article-title":"Current status of immunosuppression in liver transplantation","volume":"3","author":"Choudhary","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib39","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.3748\/wjg.15.4225","article-title":"Overview of immunosuppression in liver transplantation","volume":"15","author":"Pillai","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib40","article-title":"Management of recurrent and de novo NAFLD\/NASH after liver transplantation","author":"Germani","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jceh.2019.05.004","article-title":"Preventive strategies for nonalcoholic fatty liver disease after liver transplantation","volume":"9","author":"Choudhary","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/jlts.2001.27084","article-title":"Analysis of causes of death in liver transplant recipients who survived more than 3 years","volume":"7","author":"Pruthi","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib44","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.transproceed.2009.03.079","article-title":"De novo tumors are a major cause of late mortality after orthotopic liver transplantation","volume":"41","author":"Baccarani","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4254\/wjh.v8.i12.533","article-title":"Incidence, risk factors and outcomes of de novo malignancies post liver transplantation","volume":"8","author":"Mukthinuthalapati","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib46","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lt.25310","article-title":"Longterm risk of solid organ de novo malignancies after liver transplantation: a French national study on 11,226 patients","volume":"24","author":"S\u00e9r\u00e9e","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib47","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1600-6143.2009.02766.x","article-title":"Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients","volume":"9","author":"Finkenstedt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib48","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/lt.24795","article-title":"The 28-year incidence of de novo malignancies after liver transplantation: a single-center analysis of risk factors and mortality in 1616 patients","volume":"23","author":"Rademacher","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2020.02.001","article-title":"De Novo Malignancy after Living Donor Liver Transplantation: A Large Volume Experience","author":"Tiwari","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jlts.2002.32977","article-title":"Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation","volume":"8","author":"Saigal","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/ctr.12171","article-title":"De novo malignancy post liver transplantation: a single center, population controlled study","volume":"27","author":"Chatrath","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.transproceed.2012.01.027","article-title":"De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry","volume":"44","author":"Park","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOT.0000000000000499","article-title":"Long-term care of transplant recipients: de novo neoplasms after liver transplantation","volume":"23","author":"Burra","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib54","first-page":"417","article-title":"Posttransplant lymphoproliferative disorder in liver recipients: characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations","volume":"29","author":"Mumtaz","year":"2015","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1478-3231.2010.02303.x","article-title":"Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review","volume":"30","author":"Chak","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.06.010_bib56","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/TP.0000000000000671","article-title":"Worse long-term patient survival and higher cancer rates in liver transplant recipients with a history of smoking","volume":"99","author":"Mangus","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib57","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.06.010_bib58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ntr\/nty074","article-title":"Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis","volume":"21","author":"Asthana","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.jceh.2020.06.010_bib59","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1399-0012.2008.00927.x","article-title":"Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report","volume":"23","author":"Herrero","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib60","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/j.1600-6143.2011.03703.x","article-title":"Impact of MELD-based allocation on end-stage renal disease after liver transplantation","volume":"11","author":"Sharma","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib61","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2020.06.010_bib62","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/jlts.2002.35668","article-title":"Chronic renal dysfunction late after liver transplantation","volume":"8","author":"Cohen","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib63","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e3182884890","article-title":"Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up","volume":"95","author":"Giusto","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.dld.2008.09.018","article-title":"Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study","volume":"41","author":"Burra","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2020.06.010_bib65","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2014.03.034","article-title":"Chronic kidney disease and associated mortality after liver transplantation- A time dependent analysis using measured glomerular filtration rate","volume":"61","author":"Allen","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/TP.0b013e3181c42ff9","article-title":"Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up","volume":"89","author":"Sanchez","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib67","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2010.12.001","article-title":"Immunosuppression in liver transplant recipients with renal impairment","volume":"54","author":"Duvoux","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib68","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1600-6143.2005.00852.x","article-title":"Renal histopathological lesions after orthotopic liver transplantation (OLT)","volume":"5","author":"Pillebout","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181c353e5","article-title":"The variable pathology of kidney disease after liver transplantation","volume":"89","author":"Kim","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib70","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.12257","article-title":"Predicting end-stage renal disease after liver transplant","volume":"13","author":"Israni","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib71","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/ajt.13765","article-title":"Protecting the kidney in liver transplant recipients: practice-based recommendations from the American society of transplantation liver and intestine community of practice","volume":"16","author":"Levitsky","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib72","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.ajkd.2014.01.436","article-title":"Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients","volume":"63","author":"Shaffi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jceh.2020.06.010_bib73","first-page":"1064","volume":"11","author":"Yoshida","year":"2005","journal-title":"Transplantation Society"},{"key":"10.1016\/j.jceh.2020.06.010_bib74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the \u2018ReSpECT\u2019 study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib75","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib76","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10620-010-1386-z","article-title":"Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction","volume":"56","author":"Kornberg","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.06.010_bib78","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/lt.20903","article-title":"Mycophenolate Mofetil in Combination with Reduction of Calcineurin Inhibitors for Chronic Renal Dysfunction after Liver Transplantation","volume":"12","author":"Pageaux","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2020.06.010_bib79","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-6143.2011.03919.x","article-title":"Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial","volume":"12","author":"Abdelmalek","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib80","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/lt.21920","article-title":"Improvement of Renal Function after the Switch from a Calcineurin Inhibitor to Everolimus in Liver Transplant Recipients with Chronic Renal Dysfunction","volume":"15","author":"Castroagudin","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2020.06.010_bib81","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a Calcineurin Inhibitor to Everolimus Therapy in Maintenance Liver Transplant Recipients: A Prospective, Randomized, Multicenter Trial","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2020.06.010_bib82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jceh.2016.02.001","article-title":"Liver transplantation for alcohol-related liver disease","volume":"6","author":"Choudhary","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psym.2014.09.006","article-title":"Risk factors for alcohol relapse following orthotopic liver transplantation: a systematic review","volume":"5","author":"Rustad","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jceh.2020.06.010_bib84","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ajg.2009.226","article-title":"A\u00a0shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation","volume":"104","author":"Tandon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7182\/pit2013604","article-title":"The Alcohol Relapse Risk Assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant","volume":"23","author":"Rodrigue","year":"2013","journal-title":"Prog Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib86","article-title":"Posttransplant complications predict alcohol relapse in liver transplant recipients","author":"Kitajima","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib87","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365520410009591","article-title":"Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib88","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/lt.20688","article-title":"Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease","volume":"12","author":"DiMartini","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib89","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archinte.167.11.1183","article-title":"A\u00a0simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years","volume":"167","author":"De Gottardi","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jceh.2020.06.010_bib90","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/jlts.2002.34150","article-title":"Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation","volume":"8","author":"Pungpapong","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib92","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/TP.0b013e31820b6b84","article-title":"NAFLD recurrence in liver transplant recipients","volume":"91","author":"Dureja","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib93","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.14521","article-title":"Systematic review with meta-analysis: de novo nonalcoholic fatty liver disease in liver-transplanted patients","volume":"47","author":"Losurdo","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.06.010_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2019.02.005","article-title":"Screening of cardiovascular disease in nonalcoholic fatty liver disease","author":"Choudhary","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib95","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","article-title":"Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis","volume":"101","author":"Bhati","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib96","article-title":"Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation","author":"Narayanan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib97","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MEG.0000000000001105","article-title":"De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients","volume":"30","author":"Gitto","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib98","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.21396","article-title":"Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials","volume":"14","author":"Segev","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib99","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/00365521.2018.1463390","article-title":"Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation","volume":"53","author":"Castedal","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2036.2010.04505.x","article-title":"Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation","volume":"33","author":"Guillouche","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.06.010_bib101","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12664-015-0578-z","article-title":"Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation","volume":"34","author":"Saigal","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.06.010_bib102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jceh.2017.08.004","article-title":"Efficacy and safety of sofosbuvir based regimens for treatment of hepatitis C recurrence after living donor liver transplantation: an experience from India","volume":"8","author":"Choudhary","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib103","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/jgh.13614","article-title":"Efficacy and safety of sofosbuvir-based interferon-free therapies for hepatitis C in liver transplant recipients","volume":"32","author":"Qu","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib104","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11901-020-00507-z","article-title":"Recurrent disease after liver transplantation","volume":"19","author":"Lim","year":"2020","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jceh.2020.06.010_bib106","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.06.010_bib107","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.06.010_bib108","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of Duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2020.06.010_bib109","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.06.010_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2020.02.002","article-title":"Good long-term outcomes in patients with Primary Sclerosing Cholangitis undergoing living donor liver transplantation","author":"Choudhary","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib111","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib112","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transplant"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2020.06.010_bib113","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib114","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.06.010_bib115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib116","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.06.010_bib117","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s10620-011-1722-y","article-title":"Hepatic osteodystrophy is common in patients with noncholestatic liver disease","volume":"56","author":"Choudhary","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.06.010_bib118","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3390\/ijms20174270","article-title":"Bone diseases in patients with chronic liver disease","volume":"20","author":"Jeong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2020.06.010_bib119","article-title":"Bone disease following liver transplant","volume":"2","author":"Guadalix Iglesias","year":"2010","journal-title":"Rev Osteoporos Metab Miner"},{"key":"10.1016\/j.jceh.2020.06.010_bib120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","article-title":"Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study","volume":"357","author":"Leidig-Bruckner","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2020.06.010_bib121","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","article-title":"Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors","volume":"46","author":"Guichelaar","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.06.010_bib122","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: liver transplantation","volume":"64","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib123","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.transproceed.2009.03.073","article-title":"Menstrual function in female liver transplant recipients of reproductive age","volume":"41","author":"Jabiry-Zieniewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib124","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/ajt.14697","article-title":"Reproductive health in women following abdominal organ transplant","volume":"18","author":"Sarkar","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007890-199608270-00009","article-title":"Gynecological and reproductive function after liver transplantation","volume":"62","author":"Mass","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.06.010_bib126","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.transproceed.2004.04.090","article-title":"Fertility and contraceptive issues after kidney transplantation in women","volume":"36","author":"Lessan-Pezeshki","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jama.1985.03360020072027","article-title":"Association between diaphragm use and urinary tract infection","volume":"254","author":"Fihn","year":"1985","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jceh.2020.06.010_bib128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/j.semperi.2007.09.007","article-title":"Contraception for the transplant patient","volume":"31","author":"Estes","year":"2007","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib129","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.jceh.2020.06.010_bib130","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","article-title":"Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action","volume":"75","author":"Ortiz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jceh.2020.06.010_bib131","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2016.11.008","article-title":"Use of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series","volume":"95","author":"Huguelet","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.jceh.2020.06.010_bib132","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.transproceed.2007.02.063","article-title":"Low-dose hormonal contraception after liver transplantation","volume":"39","author":"Jabiry-Zieniewicz","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib133","article-title":"Pregnancy after liver transplantation: outcomes from a single-center experience","author":"Sivaprasadan","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib134","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.transproceed.2019.01.014","article-title":"Pregnancy outcomes after liver transplantation: a systematic review","volume":"51","author":"Prodromidou","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.06.010_bib135","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/lt.24483","article-title":"Pregnancy in the liver transplant recipient","volume":"22","author":"Jabiry-Zieniewicz","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2020.06.010_bib136","first-page":"505","article-title":"The ABCs of immunosuppression: a primer for primary care physicians","volume":"100","author":"Malat","year":"2016","journal-title":"Med Clin"},{"key":"10.1016\/j.jceh.2020.06.010_bib137","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"Electronic address: easloffice@easloffice.eu; European association for the study of the liver. EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.06.010_bib138","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/amj.2018.01.07","article-title":"Immunosuppressive pharmacotherapy in liver transplantation","volume":"3","author":"Hussaini","year":"2018","journal-title":"AME Med J"},{"key":"10.1016\/j.jceh.2020.06.010_bib139","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/2193-1801-3-168","article-title":"Potential Statin-Drug Interactions: Prevalence and Clinical Significance","volume":"3","author":"Zhelyazkova-Savova","year":"2014","journal-title":"Springer Plus"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320300979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320300979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:32Z","timestamp":1760853992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688320300979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0973688320300979"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2020.06.010","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Management of the Adult Liver Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}